J9075 – Injection, cyclophosphamide, not otherwise specified, 5 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ9075
- Long description
- Injection, cyclophosphamide, not otherwise specified, 5 mg
- Short description
- Inj, cyclophosphamide, nos
- Pricing indicator
51Drugs- Medicare coverage
DSpecial coverage instructions apply- BETOS category
O1DChemotherapy- ASC
- Approved for ambulatory surgical centers
- Added
- April 1, 2024
- Last change
- April 1, 2024 – No change
Frequently asked questions
What is HCPCS code J9075?
J9075 is a HCPCS Level II code for injection, cyclophosphamide, not otherwise specified, 5 mg.
Does Medicare cover J9075?
The HCPCS file lists coverage code D: Special coverage instructions apply. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J9064 – Injection, cabazitaxel (sandoz), not therapeutically equivalent to j9043, 1 mg
- J9065 – Injection, cladribine, per 1 mg
- J9066 – Injection, bendamustine hydrochloride (avyxa), 1 mg
- J9070 – Cyclophosphamide, 100 mg
- J9071 – Injection, cyclophosphamide (auromedics), 5 mg
- J9072 – Injection, cyclophosphamide (frindovyx), 5 mg
- J9073 – Injection, cyclophosphamide (dr. reddy's), 5 mg
- J9074 – Injection, cyclophosphamide (sandoz), 5 mg
- J9076 – Injection, cyclophosphamide (baxter), 5 mg
- J9098 – Injection, cytarabine liposome, 10 mg
- J9100 – Injection, cytarabine, 100 mg
- J9118 – Injection, calaspargase pegol-mknl, 10 units
- J9119 – Injection, cemiplimab-rwlc, 1 mg
- J9120 – Injection, dactinomycin, 0.5 mg
- J9130 – Dacarbazine, 100 mg
- J9144 – Injection, daratumumab, 10 mg and hyaluronidase-fihj
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.